EMGALITY® (galcanezumab-gnlm): Aseptic Techniques During Supply Shortages

Injection Aseptic Techniques

Patients should follow the guidance on good aseptic techniques, such as handwashing and use of alcohol wipes, as outlined in the galcanezumab “Instructions for Use.”^1,2

Guidance During Medical Supply Shortages

The COVID-19 pandemic has caused widespread medical supply shortages, including alcohol swabs and bottles of 70% isopropyl alcohol.

During shortages, patients should contact their health care provider for suggested alternative aseptic measures.

Injection Site Preparation

As an alternative to the use of alcohol, the WHO recommends the use of soap and water for skin preparation and disinfection of injection sites.³

Enclosed Prescribing Information

EMGALITY® (galcanezumab-gnlm) injection, for subcutaneous use, Lilly

References

The published references below are available by contacting 1-800-LillyRx (1-800-545-5979).

1. EMGALITY [instructions for use, prefilled pen]. Eli Lilly and Company: Indianapolis, IN; 2019.

2. EMGALITY [instructions for use, prefilled syringe]. Eli Lilly and Company: Indianapolis, IN; 2019.

3. World Health Organization. WHO best practices for injections and related procedures toolkit. Published March 2010. Accessed March 23, 2020. https://apps.who.int/iris/bitstream/handle/10665/44298/9789241599252_eng.pdf?sequence=1

Glossary

COVID-19 = coronavirus disease 2019

Lilly = Eli Lilly and Company

WHO = World Health Organization